UUֱ

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Iron nanoparticles - ‘rustproof transition’ from diagnostics to therapeutics

26 April 2022 14:00-15:00, United Kingdom


Introduction
The recent COVID-19 pandemic highlighted RT PCR for rapid, easy detection and containment of the disease.
We exemplify herein our pioneering contributions, with Biochemistry, Chemistry and Process Chemistry to projects in diagnostics and therapeutics. We coupled our expertise in PCR with extensive research on multifarious applications of uncoated nanoparticles of iron oxide. A spectacular confluence of advances in these and in cognate fields have led to dramatic transformation in diagnosis and treatment of diseases.

Multiple drug resistance remains a challenge; we aim to meet this in non-traditional/unconventional ways. Using clues gleaned from multifaceted molecules in nature, we achieved good results highlighting diverse applications of uncoated nanoparticles of iron oxide (replacing gold nanoparticles) in

1. boosting PCR in molecular diagnostics,
2. arresting amyloid polymerization
3. Inducing glial cell differentiation.

Our studies on hitherto overlooked iron oxide nanoparticles, will unravel, epitomize, and focus on their untapped potential in developing possible cures for “impossible” diseases
Speakers
Venue

United Kingdom

Contact information
Dr Fraser Kerr
Astute Pharma Associates Ltd
0044 792 0082985
Contact us by email

Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*